Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00218569
Status:
COMPLETED
Last Update Posted:
2016-01-27
First Post:
2005-09-20
Brief Title:
Combined Treatment for Cocaine-Alcohol Dependence - 1
Sponsor:
The University of Texas Health Science Center Houston
Organization:
The University of Texas Health Science Center Houston
Study Overview
Official Title:
Combined Treatment for Cocaine-Alcohol Dependence
Status:
COMPLETED
Status Verified Date:
2016-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to examine whether Naltrexone and cognitive behavioral therapy can be helpful in patients who want to stop using cocaine and alcohol
Detailed Description:
This is a randomized double blind placebo-controlled trial to examine the role of Relapse Prevention RP and Contingency Management CMP combined with Naltrexone NTX for the treatment of cocaine-alcohol dependence Patients will be randomly assigned to NTX 100mgd or placebo combined with one of two psychotherapy conditions RP or RP CMP Following a standardized consent and intake procedure patients will participate in a 12-week trial with thrice weekly visits Manual-guided RP therapy will be delivered in weekly 60-minute individual sessions CMP will be based on cocaine-negative urine screens and negative breath alcohol tests Follow-up assessments will be conducted at 3 and 6 months after treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01-15801-1 | US NIH GrantContract | None | httpsreporternihgovquickSearchR01DA015801 |
| R01DA015801 | NIH | None | None |